BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21303834)

  • 1. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
    Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
    Lupus; 2011 Feb; 20(2):174-81. PubMed ID: 21303834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
    Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
    Lupus; 2011 Feb; 20(2):165-73. PubMed ID: 21303833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
    Pierangeli SS; de Groot PG; Dlott J; Favaloro E; Harris EN; Lakos G; Ortel T; Meroni PL; Otomo K; Pengo V; Tincani A; Wong R; Roubey R
    Lupus; 2011 Feb; 20(2):182-90. PubMed ID: 21303835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
    Bertolaccini ML; Amengual O; Atsumi T; Binder WL; de Laat B; Forastiero R; Kutteh WH; Lambert M; Matsubayashi H; Murthy V; Petri M; Rand JH; Sanmarco M; Tebo AE; Pierangeli SS
    Lupus; 2011 Feb; 20(2):191-205. PubMed ID: 21303836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid Syndrome Clinical Research Task Force report.
    Erkan D; Derksen R; Levy R; Machin S; Ortel T; Pierangeli S; Roubey R; Lockshin M
    Lupus; 2011 Feb; 20(2):219-24. PubMed ID: 21303838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.
    Ruiz-Irastorza G; Cuadrado MJ; Ruiz-Arruza I; Brey R; Crowther M; Derksen R; Erkan D; Krilis S; Machin S; Pengo V; Pierangeli S; Tektonidou M; Khamashta M
    Lupus; 2011 Feb; 20(2):206-18. PubMed ID: 21303837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
    Branch W;
    Lupus; 2011 Feb; 20(2):158-64. PubMed ID: 21303832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hematologic manifestations of the antiphospholipid syndrome.
    Uthman I; Godeau B; Taher A; Khamashta M
    Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
    Miyakis S; Lockshin MD; Atsumi T; Branch DW; Brey RL; Cervera R; Derksen RH; DE Groot PG; Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA
    J Thromb Haemost; 2006 Feb; 4(2):295-306. PubMed ID: 16420554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment.
    Galli M; Finazzi G; Barbui T
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():24-7. PubMed ID: 8952756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
    Cervera R; Font J; Gómez-Puerta JA; Espinosa G; Cucho M; Bucciarelli S; Ramos-Casals M; Ingelmo M; Piette JC; Shoenfeld Y; Asherson RA;
    Ann Rheum Dis; 2005 Aug; 64(8):1205-9. PubMed ID: 15708888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.
    Abreu MM; Danowski A; Wahl DG; Amigo MC; Tektonidou M; Pacheco MS; Fleming N; Domingues V; Sciascia S; Lyra JO; Petri M; Khamashta M; Levy RA
    Autoimmun Rev; 2015 May; 14(5):401-14. PubMed ID: 25641203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome in dermatology: an update.
    Rai R; Sekar CS; Kumaresan M
    Indian J Dermatol Venereol Leprol; 2010; 76(2):116-24. PubMed ID: 20228539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
    Kaul M; Erkan D; Sammaritano L; Lockshin MD
    Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic antiphospholipid syndrome: task force report summary.
    Cervera R; Rodríguez-Pintó I;
    Lupus; 2014 Oct; 23(12):1283-5. PubMed ID: 25228727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
    Cervera R; Espinosa G; Cordero A; Oltra MR; Unzurrunzaga A; Rossiñol T; Plaza J; Bucciarelli S; Ramos-Casals M; Ingelmo M; Asherson RA; Font J;
    Semin Arthritis Rheum; 2007 Apr; 36(5):287-96. PubMed ID: 17207521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.